Advertisement

Abrogation of IL-3 Dependence of Myeloid FDC-P1 Cells by Tyrosine Kinase Oncogenes Is Associated with Induction of c-myc

  • J. L. Cleveland
  • M. Dean
  • J. Y. Wang
  • A.-M. Hedge
  • J. N. Ihle
  • U. R. Rapp
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 141)

Abstract

A role for the c-myc proto-oncogene in growth factor signal transduction first came from experiments showing that the gene was inducible by treating quiescent T cells and fibroblasts with experimental mitogens or growth factors (Kelly et al., 1983). Subsequently, subtractive cDNA cloning from PDGF-treated fibroblast cells identified c-myc as an early Gl or competence gene in these cells (Cochran et al., 1983). Significance for this induction was established from studies demonstrating that introduction of constitutively expressed source of exogenous c-myc or microinjection of purified c-myc protein relieved the requirements for PDGF in the transition from GO into Gl (Armelin et al., 1984; Kaczmarek et al., 1985).

Keywords

Burkitt Lymphoma Permissive Temperature Virus Clone Promoter Usage Factor Independence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armelin HA, Armelin MCS, Kelly, K, Stewart T, Leder P, Cochran BH, Stiles CD (1984) Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 310: 655–660PubMedCrossRefGoogle Scholar
  2. Bentley D, Groudine M (1986) A block tom elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (London) 321: 702–706PubMedCrossRefGoogle Scholar
  3. Cochran BH, Reffel AC, Stiles CD (1983) Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939–683PubMedCrossRefGoogle Scholar
  4. Dean M, Cleveland JL, Rapp UR, Ihle JN (1987) Role of myc in the abrogation of IL-3 dependence of myeloid FDC-pl cells. Oncogene Res. 1: 279–296PubMedGoogle Scholar
  5. Eick D, Bornkam G (1986) Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res. 14: 8331–8346PubMedCrossRefGoogle Scholar
  6. Kaczmarek L, Hyland JK, Watt R, Rosenbert M, Baserga R (1985) Microinjected c-myc as a competence factor. Science 228: 1313–1315PubMedCrossRefGoogle Scholar
  7. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603–610PubMedCrossRefGoogle Scholar
  8. Mathey-Prevot B, Nabel G, Palacios R, Baltimore D (1986) Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell. Biol. 6: 4133–4135Google Scholar
  9. Mechti N, Piechaczyk M, Blanchard J-M, Marty L, Jeanteur P, LeBleu B (1986) Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res. 14: 9653–9666PubMedCrossRefGoogle Scholar
  10. Pelicci PG, Knowles DM, Magrath I, Dalla-Favera R (1986) Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. U.S.A. 83: 2984–2988PubMedCrossRefGoogle Scholar
  11. Pierce JH, DeFiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN (1985) Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a non-autocrine mechanism. Cell 41: 685–693PubMedCrossRefGoogle Scholar
  12. Pierce JH, Ruggiero M, Fleming TP, DeFiore PP, Greenberger JS, Varticovski L, Schlessinger J, Rovera G, Aaronson SA (1988) Signal transduction through the EGF receptor transfected in IL-3 dependent hematopoietic cells. Science 239: 628–631PubMedCrossRefGoogle Scholar
  13. Rapp UR, Cleveland JL, Brightman K, Scott A, Ihle JN (1985) Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature (London) 317: 434–438PubMedCrossRefGoogle Scholar
  14. Wheeler EF, Askew D, May S, Ihle JN, Scherr CJ (1987) The v-fms oncogene induces factor independent growth and transformation of the IL-3 dependent cell line, FDC-P1. Mol. Cell. Biol. 7: 1673–1680Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1988

Authors and Affiliations

  • J. L. Cleveland
    • 1
  • M. Dean
    • 2
  • J. Y. Wang
    • 3
  • A.-M. Hedge
    • 4
  • J. N. Ihle
    • 4
  • U. R. Rapp
    • 1
  1. 1.Laboratory of Viral Carcinogenesis/NCI-FCRFFrederickUSA
  2. 2.Program Resources Inc.FrederickUSA
  3. 3.University of California at San DiegoLa JollaUSA
  4. 4.Bionetics Research InstituteFrederickUSA

Personalised recommendations